[CHEK2-associated hereditary breast cancer]

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• CHEK2 is a moderate-penetrance gene associated with hereditary breast cancer (BC).
• In Russia, CHEK2 mutations are the second most common cause of BC after BRCA1 mutations.
• Specific gene-inactivating CHEK2 alleles include 1100delC, del5395, and IVS2+1G>A.

Purpose of the Study:

• To highlight the clinical significance of CHEK2 mutations in hereditary breast cancer.
• To emphasize the need for routine CHEK2 testing in clinical practice.

Main Methods:

• This abstract does not detail specific methods.
• The study focuses on the genetic and clinical aspects of CHEK2 in breast cancer.

Main Results:

• CHEK2 mutations are prevalent in the Russian population, second only to BRCA1.
• CHEK2-associated breast carcinomas typically present with poor prognosis.
• These tumors often exhibit low sensitivity to standard therapeutic interventions.

Conclusions:

• CHEK2 testing holds significant clinical importance for hereditary breast cancer management.
• Routine integration of CHEK2 mutation analysis into clinical practice is recommended.